Aurinia Pharmaceuticals Inc Analysis
| Analyst Ratings |
|
Average Target Price
|
12.07
|
|
Average Rating
|
4.13
|
|
# Strong Buys
|
3
|
|
# Buys
|
3
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.17
|
-0.06
|
0.11
|
64.71%
|
|
2022-06-30
|
-0.22
|
-0.25
|
-0.03
|
-13.64%
|
|
2022-03-31
|
-0.27
|
-0.27
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.27
|
-0.25
|
0.02
|
7.41%
|
|
2021-09-30
|
-0.33
|
-0.39
|
-0.06
|
-18.18%
|
|
2021-06-30
|
-0.36
|
-0.37
|
-0.01
|
-2.78%
|
|
2021-03-31
|
-0.36
|
-0.40
|
-0.04
|
-11.11%
|
|
2020-12-31
|
-0.24
|
-0.05
|
0.19
|
79.17%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.58
|
|
2021-12-31
|
-1.41
|
|
2020-12-31
|
-0.74
|
|
2019-12-31
|
-1.30
|
|
2018-12-31
|
-0.75
|
|
2017-12-31
|
-1.15
|
|
2016-12-31
|
-0.66
|
|
2015-12-31
|
-0.58
|
|
2014-12-31
|
-0.60
|
|
2013-12-31
|
-1.28
|
|
2008-12-31
|
-9.50
|
|
2007-12-31
|
-16.00
|
|
2006-12-31
|
-15.50
|
|
2005-12-31
|
-20.50
|
|
2004-12-31
|
-18.00
|
|
2003-12-31
|
-13.00
|
|
2002-12-31
|
-0.50
|